Spark Therapeutics +122% after the acquisition news by Roche
Swiss pharmaceutical company Roche Holding AG announced that it has reached a final agreement for acquisition of Spark Therapeutics from Philadelphia. Roche offered $114.50 for each share of Spark Therapeutics, which is 122% more than Friday’s closing price. Spark Therapeutics...